Advances are helping people born with heart defects to make it into adulthood and retirement age. Medical care hasn't kept up ...

specifically pulmonary hypertension secondary to left heart failure with preserved ejection fraction (“PH-HFpEF”). In patients with PH-HFpEF, chronic heart failure leads to increased blood pressure in ...

Cardiovascular disease, sometimes abbreviated as CVD, is the leading cause of death worldwide. It’s a catchall term for heart ...

Although finerenone has kidney protective effects in patients with chronic kidney disease and type 2 diabetes, it does not appear to slow kidney function decline in patients with heart failure with ...

Background Heart failure (HF) is a leading cause of morbidity and mortality worldwide. Serum uric acid (SUA), a product of ...

An analysis of the FINEARTS-HF trial, which showed finerenone's benefits in heart failure outcomes, shows no significant ...

Scientists at the Gladstone Institutes have discovered how immune cells in the heart ... failure. This type of fibrosis becomes particularly common with aging and in people suffering from chronic ...

Background: Diabetes mellitus is associated with an increased risk of death and hospitalisation in patients with chronic heart failure. Better understanding ... despite higher left ventricular ...

American Heart Association (AHA) poster to be presented on November 16, 2024WATERTOWN, Mass., Oct. 22, 2024 (GLOBE NEWSWIRE) -- Tectonic Therapeutic, Inc. (NASDAQ: TECX) (Tectonic), a clinical stage ...

Later in life it can show up as an often fatal condition known as heart failure with preserved ejection fraction. Ussher is devoting his research career to finding treatments for this hidden disease.